Zi Long Qian
Director Ejecutivo en SHENZHEN KINGSINO TECHNOLOGY CO.,LTD. .
Fortuna: 179 683 $ al 31/05/2024
Cargos activos de Zi Long Qian
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SHENZHEN KINGSINO TECHNOLOGY CO.,LTD. | Director Ejecutivo | 28/10/2022 | - |
Wuhan Huayang Animal Pharmaceutical Co., Ltd.
 Wuhan Huayang Animal Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Huayang Animal Pharmaceutical Co., Ltd. is a private company that manufactures and sells veterinary drugs, aquatic feed drug additives, and aquaculture fertilizer. The company is based in Wuhan, China. Wuhan Huayang Animal Pharmaceutical Co. was acquired by Wuhan Huayang Animal Pharmaceutical Co. Ltd. /Sun/ from Shenzhen Kingsino Technology Co., Ltd. on April 16, 2022 for $24.21 million. The Chinese company was founded in 2000. The CEO is Jin Lin Zhang. | Director/Miembro de la Junta | - | - |
Historial de carrera de Zi Long Qian
Formación de Zi Long Qian.
| China University of Geosciences | Undergraduate Degree |
| Sun Yat-Sen University | Masters Business Admin |
Estadísticas
Internacional
| China | 5 |
Operativa
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
| Process Industries | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SHENZHEN KINGSINO TECHNOLOGY CO.,LTD. | Process Industries |
| Empresas privadas | 1 |
|---|---|
Wuhan Huayang Animal Pharmaceutical Co., Ltd.
Wuhan Huayang Animal Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Huayang Animal Pharmaceutical Co., Ltd. is a private company that manufactures and sells veterinary drugs, aquatic feed drug additives, and aquaculture fertilizer. The company is based in Wuhan, China. Wuhan Huayang Animal Pharmaceutical Co. was acquired by Wuhan Huayang Animal Pharmaceutical Co. Ltd. /Sun/ from Shenzhen Kingsino Technology Co., Ltd. on April 16, 2022 for $24.21 million. The Chinese company was founded in 2000. The CEO is Jin Lin Zhang. | Health Technology |
- Bolsa de valores
- Insiders
- Zi Long Qian
- Experiencia
